Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 321

1.

Spatio-temporal patterns of orchids flowering in Cameroonian rainforests.

Texier N, Deblauwe V, Stévart T, Sonké B, Simo-Droissart M, Azandi L, Bose R, Djuikouo MN, Kamdem G, Kamdem N, Mayogo S, Zemagho L, Droissart V.

Int J Biometeorol. 2018 Sep 13. doi: 10.1007/s00484-018-1594-3. [Epub ahead of print]

PMID:
30215186
2.

The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Sep 4;9(1):3476. doi: 10.1038/s41467-018-05914-x.

3.

Reply to J.J. Tao et al.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Aug 10;36(23):2451. doi: 10.1200/JCO.2018.78.6392. Epub 2018 Jun 1. No abstract available.

PMID:
29856693
4.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.

Gullo G, Walsh N, Fennelly D, Bose R, Walshe J, Tryfonopoulos D, O'Mahony K, Hammond L, Silva N, McDonnell D, Ballot J, Quinn C, McDermott EW, Evoy D, Prichard R, Geraghty J, Amstrong J, Crown J.

Br J Cancer. 2018 Aug;119(3):374-380. doi: 10.1038/s41416-018-0114-x. Epub 2018 May 18.

PMID:
29773838
5.

Evaluation of the quality of transesophageal echocardiography images and verification of proficiency.

Matyal R, Mahmood F, Knio ZO, Jones S, Yeh L, Amir R, Bose R, Mitchell JD.

Echo Res Pract. 2018 May 9. pii: ERP-18-0002. doi: 10.1530/ERP-18-0002. [Epub ahead of print]

6.

Biological Response to Time-Controlled Adaptive Ventilation Depends on Acute Respiratory Distress Syndrome Etiology.

Silva PL, Cruz FF, Samary CDS, Moraes L, de Magalhães RF, Fernandes MVS, Bose R, Pelegati VB, Carvalho HF, Capelozzi VL, Satalin J, Gatto L, Andrews P, Habashi N, Nieman G, Rocco PRM.

Crit Care Med. 2018 Jun;46(6):e609-e617. doi: 10.1097/CCM.0000000000003078.

PMID:
29485489
7.

Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.

Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA.

Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13.

PMID:
29442264
8.

Summative Objective Structured Clinical Examination Assessment at the End of Anesthesia Residency for Perioperative Ultrasound.

Mitchell JD, Amir R, Montealegre-Gallegos M, Mahmood F, Shnider M, Mashari A, Yeh L, Bose R, Wong V, Hess P, Amador Y, Jeganathan J, Jones SB, Matyal R.

Anesth Analg. 2018 Jun;126(6):2065-2068. doi: 10.1213/ANE.0000000000002826.

PMID:
29381519
9.

Decreased Clinical Severity of Strangles in Weanlings Associated with Restricted Seroconversion to Optimized Streptococcus equi ssp equi Assays.

Tscheschlok L, Venner M, Steward K, Böse R, Riihimäki M, Pringle J.

J Vet Intern Med. 2018 Jan;32(1):459-464. doi: 10.1111/jvim.15037.

10.

Sox2 is required for olfactory pit formation and olfactory neurogenesis through BMP restriction and Hes5 upregulation.

Panaliappan TK, Wittmann W, Jidigam VK, Mercurio S, Bertolini JA, Sghari S, Bose R, Patthey C, Nicolis SK, Gunhaga L.

Development. 2018 Jan 19;145(2). pii: dev153791. doi: 10.1242/dev.153791.

11.

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Feb 20;36(6):536-542. doi: 10.1200/JCO.2017.75.3780. Epub 2018 Jan 10.

PMID:
29320312
12.

Molybdenum Sulphoselenophosphide Spheroids as an Effective Catalyst for Hydrogen Evolution Reaction.

Bose R, Jothi VR, Koh B, Jung C, Yi SC.

Small. 2018 Feb;14(8). doi: 10.1002/smll.201703862. Epub 2018 Jan 10.

PMID:
29318738
13.

Ubiquitin Ligase Huwe1 Modulates Spermatogenesis by Regulating Spermatogonial Differentiation and Entry into Meiosis.

Bose R, Sheng K, Moawad AR, Manku G, O'Flaherty C, Taketo T, Culty M, Fok KL, Wing SS.

Sci Rep. 2017 Dec 19;7(1):17759. doi: 10.1038/s41598-017-17902-0.

14.

Analyzing text recognition from tactually evoked EEG.

Khasnobish A, Datta S, Bose R, Tibarewala DN, Konar A.

Cogn Neurodyn. 2017 Dec;11(6):501-513. doi: 10.1007/s11571-017-9452-2. Epub 2017 Sep 6.

PMID:
29147143
15.

Survival trends in glioma: Experience at a tertiary care centre.

Bose R, Narang KS, Bhangale D, Kedia R, Sharma V, Jha AN.

Neurol India. 2017 Nov-Dec;65(6):1295-1301. doi: 10.4103/0028-3886.217968.

PMID:
29133704
16.

Huwe1 Regulates the Establishment and Maintenance of Spermatogonia by Suppressing DNA Damage Response.

Fok KL, Bose R, Sheng K, Chang CW, Katz-Egorov M, Culty M, Su S, Yang M, Ruan YC, Chan HC, Iavarone A, Lasorella A, Cencic R, Pelletier J, Nagano M, Xu W, Wing SS.

Endocrinology. 2017 Nov 1;158(11):4000-4016. doi: 10.1210/en.2017-00396.

PMID:
28938460
17.

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types.

Kumar RD, Bose R.

Sci Rep. 2017 Jul 25;7(1):6418. doi: 10.1038/s41598-017-06366-x.

18.

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Ma CX, Bose R, Gao F, Freedman RA, Telli ML, Kimmick G, Winer E, Naughton M, Goetz MP, Russell C, Tripathy D, Cobleigh M, Forero A, Pluard TJ, Anders C, Niravath PA, Thomas S, Anderson J, Bumb C, Banks KC, Lanman RB, Bryce R, Lalani AS, Pfeifer J, Hayes DF, Pegram M, Blackwell K, Bedard PL, Al-Kateb H, Ellis MJC.

Clin Cancer Res. 2017 Oct 1;23(19):5687-5695. doi: 10.1158/1078-0432.CCR-17-0900. Epub 2017 Jul 5.

PMID:
28679771
19.

ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.

Bose R, Karthaus WR, Armenia J, Abida W, Iaquinta PJ, Zhang Z, Wongvipat J, Wasmuth EV, Shah N, Sullivan PS, Doran MG, Wang P, Patruno A, Zhao Y; International SU2C/PCF Prostate Cancer Dream Team, Zheng D, Schultz N, Sawyers CL.

Nature. 2017 Jun 29;546(7660):671-675. doi: 10.1038/nature22820. Epub 2017 Jun 14.

20.

Co-catalytic Effects of CoS2 on the Activity of the MoS2 Catalyst for Electrochemical Hydrogen Evolution.

Bose R, Jin Z, Shin S, Kim S, Lee S, Min YS.

Langmuir. 2017 Jun 13;33(23):5628-5635. doi: 10.1021/acs.langmuir.7b00580. Epub 2017 Jun 2.

PMID:
28544849

Supplemental Content

Loading ...
Support Center